202 related articles for article (PubMed ID: 27088930)
21. Topical vitamin D₃ analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions.
Sato-Deguchi E; Imafuku S; Chou B; Ishii K; Hiromatsu K; Nakayama J
Br J Dermatol; 2012 Jul; 167(1):77-84. PubMed ID: 22384824
[TBL] [Abstract][Full Text] [Related]
22. Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions.
Cordiali-Fei P; Trento E; D'Agosto G; Bordignon V; Mussi A; Ardigó M; Mastroianni A; Vento A; Solivetti F; Berardesca E; Ensoli F
Ann N Y Acad Sci; 2007 Sep; 1110():578-89. PubMed ID: 17911474
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis.
Hegyi Z; Zwicker S; Bureik D; Peric M; Koglin S; Batycka-Baran A; Prinz JC; Ruzicka T; Schauber J; Wolf R
J Invest Dermatol; 2012 May; 132(5):1416-24. PubMed ID: 22402441
[TBL] [Abstract][Full Text] [Related]
24. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.
Brunner PM; Glitzner E; Reininger B; Klein I; Stary G; Mildner M; Uhrin P; Sibilia M; Stingl G
Exp Dermatol; 2015 Jul; 24(7):522-8. PubMed ID: 25828150
[TBL] [Abstract][Full Text] [Related]
25. Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis.
de Jong EM; Ferrier CM; de Zwart A; Wauben-Penris PJ; Korstanje C; van de Kerkhof PC
J Dermatol Sci; 1995 May; 9(3):185-94. PubMed ID: 8664216
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis.
Kawaguchi M; Mitsuhashi Y; Kondo S
Br J Dermatol; 2005 May; 152(5):915-9. PubMed ID: 15888146
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity.
Abdel-Hamid MF; Aly DG; Saad NE; Emam HM; Ayoub DF
J Dermatol; 2011 May; 38(5):442-6. PubMed ID: 21352285
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients.
Elango T; Thirupathi A; Subramanian S; Dayalan H; Gnanaraj P
Clin Chim Acta; 2015 Dec; 451(Pt B):329-37. PubMed ID: 26499845
[TBL] [Abstract][Full Text] [Related]
29. Picea mariana polyphenolic extract inhibits phlogogenic mediators produced by TNF-α-activated psoriatic keratinocytes: Impact on NF-κB pathway.
García-Pérez ME; Allaeys I; Rusu D; Pouliot R; Janezic TS; Poubelle PE
J Ethnopharmacol; 2014; 151(1):265-78. PubMed ID: 24189030
[TBL] [Abstract][Full Text] [Related]
30. Persistent expression of interleukin-17 and downstream effector cytokines in recalcitrant psoriatic lesions after ustekinumab treatment.
Kim BR; Kim M; Yang S; Choi CW; Lee KS; Youn SW
J Dermatol; 2021 Jun; 48(6):876-882. PubMed ID: 33860544
[TBL] [Abstract][Full Text] [Related]
31. IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation.
Balato A; Lembo S; Mattii M; Schiattarella M; Marino R; De Paulis A; Balato N; Ayala F
Exp Dermatol; 2012 Nov; 21(11):892-4. PubMed ID: 23163661
[TBL] [Abstract][Full Text] [Related]
32. Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression.
Debets R; Hegmans JP; Buurman WA; Benner R; Prens EP
Cytokine; 1996 Jan; 8(1):80-8. PubMed ID: 8742070
[TBL] [Abstract][Full Text] [Related]
33. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
34. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.
Funding AT; Johansen C; Kragballe K; Otkjaer K; Jensen UB; Madsen MW; Fjording MS; Finnemann J; Skak-Nielsen T; Paludan SR; Iversen L
J Invest Dermatol; 2006 Aug; 126(8):1784-91. PubMed ID: 16543895
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques.
Faurschou A; Pedersen J; Gyldenløve M; Poulsen SS; Holst JJ; Thyssen JP; Zachariae C; Vilsbøll T; Skov L; Knop FK
Exp Dermatol; 2013 Feb; 22(2):150-2. PubMed ID: 23362875
[TBL] [Abstract][Full Text] [Related]
36. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
37. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression.
Johnston A; Xing X; Guzman AM; Riblett M; Loyd CM; Ward NL; Wohn C; Prens EP; Wang F; Maier LE; Kang S; Voorhees JJ; Elder JT; Gudjonsson JE
J Immunol; 2011 Feb; 186(4):2613-22. PubMed ID: 21242515
[TBL] [Abstract][Full Text] [Related]
38. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
Chiricozzi A; Guttman-Yassky E; Suárez-Fariñas M; Nograles KE; Tian S; Cardinale I; Chimenti S; Krueger JG
J Invest Dermatol; 2011 Mar; 131(3):677-87. PubMed ID: 21085185
[TBL] [Abstract][Full Text] [Related]
39. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings.
Asadullah K; Friedrich M; Hanneken S; Rohrbach C; Audring H; Vergopoulos A; Ebeling M; Döcke WD; Volk HD; Sterry W
J Invest Dermatol; 2001 May; 116(5):721-7. PubMed ID: 11348460
[TBL] [Abstract][Full Text] [Related]
40. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
